Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

Volume XXIV No. 16 - November 20, 2017

Is the Worm Turning in Favor of Hospital Labs?

Commentary and Opinion by R. Lewis Dark /

SINCE THE MID-1990S, HOSPITAL OUTREACH LABORATORY PROGRAMS have lost market share steadily to the nation’s biggest public lab companies. In these two decades, public lab companies traded deeply-discounted lab test prices to health insurers in exchange for exclusive network provider status. Then, about eight years ago, having captured many managed-care contracts across the nation, big […]

To access this post, you must purchase The Dark Report.

Is the Worm Turning in Favor of Hospital Labs? Read More »

Paths of Hospital Labs, Independent Labs Diverge

Clinical Laboratory Trends /

CEO SUMMARY: With each passing year, the primary role of hospital and health system labs evolves in a different direction than that of independent lab companies. This trend is a response to the creation of integrated delivery networks paid on value and how they are scored on their ability to keep patients out of hospitals

To access this post, you must purchase The Dark Report.

Paths of Hospital Labs, Independent Labs Diverge Read More »

Surprisingly Low Price Paid for Miraca’s AP Lab Is a Warning

Laboratory Management /

EVEN INTO THE MID 1980s, coal miners used canaries as an early-detection system for the presence of carbon monoxide and other toxic gases. In this way, canaries served as a sentinel species to save miners’ lives. Clinical laboratories and pathology groups don’t have a sentinel species to warn them about trouble ahead, but they do

To access this post, you must purchase The Dark Report.

Surprisingly Low Price Paid for Miraca’s AP Lab Is a Warning Read More »

Fla. Lab Sells to Labcorp, But Keeps Nursing Homes

Laboratory Management /

CEO SUMMARY: Vista Clinical Diagnostics of Clermont, Fla., is betting big on the nursing home sector just when many labs serving nursing homes are worried about steep Medicare cuts coming Jan. 1. After selling its physician office referral testing, 35 patient service centers, and a mobile testing service to LabCorp, Vista will retain its nursing

To access this post, you must purchase The Dark Report.

Fla. Lab Sells to Labcorp, But Keeps Nursing Homes Read More »

Tougher Times Ahead as Labs React to Fee Cuts

Laboratory Management /

CEO SUMMARY: Just as Nero is reputed to have fiddled while Rome burned, officials at CMS seem to be doing their own fiddling as their planned deep price cuts to Medicare Part B lab tests could begin driving lab companies out of business. In recent weeks, the owners of two lab companies decided to sell

To access this post, you must purchase The Dark Report.

Tougher Times Ahead as Labs React to Fee Cuts Read More »

CMS Publishes Final CLFS Rates, Labs Prepare to Cut Staff or Close

Laboratory Billing /

MEDICARE OFFICIALS PUBLISHED the final Part B Clinical Laboratory Fee Schedule for 2018 last Friday. Some changes clinical labs will welcome. The rates remain deeply flawed, however, and will cause many labs to lay off staff and others to close, experts said Saturday. How CMS set the rates remains problematic, stated Julie Khani, President of

To access this post, you must purchase The Dark Report.

CMS Publishes Final CLFS Rates, Labs Prepare to Cut Staff or Close Read More »

FDA Clears Waived CBC For Near-Patient Testing

Clinical Laboratory /

CEO SUMMARY: Market clearance of the first-ever CLIA-waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer Sysmex America, Inc., foresees its analyzer as a complement to central labs. Basic diagnostics would be

To access this post, you must purchase The Dark Report.

FDA Clears Waived CBC For Near-Patient Testing Read More »

November 20, 2017 Intelligence: Late Breaking Lab News

Late Breaking Lab News /

Last Friday, Roche announced an agreement to acquire Viewics, Inc., of Sunnyvale, Calif., in a transaction that, subject to regulatory clearance, is expected to close on Nov. 21. Viewics sells a middleware analytics solution to clinical labs. Terms of the sale were not announced. Viewics was founded in 2010. SUNQUEST IN DEAL WITH N-OF-ONE Earlier

To access this post, you must purchase The Dark Report.

November 20, 2017 Intelligence: Late Breaking Lab News Read More »

Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;